Literature DB >> 7506676

Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P.

S Zoffmann1, U Gether, T W Schwartz.   

Abstract

Residue number 17 in transmembrane segment VI has been shown to be crucial for the binding of agonists in G-protein-coupled receptors for the monoamines. In many peptide receptors a histidyl residue has been conserved at this position. We find that replacement of HisVI-17 in the NK-1 receptor with either glutamine, phenylalanine, or alanine has no apparent effect on the binding of the natural peptide ligand substance P or on the agonist induced increase in inositolphosphate turnover. However, the binding of certain non-peptide antagonists was impaired; for example, replacement of HisVI-17 with alanine decreased the affinity for FK888 and RP67,580 5- to 12-fold, respectively. A glutamine side chain was a good substitute for the imidazole in the binding of all non-peptide antagonists. It is concluded that the conserved HisVI-17 in the NK-1 receptor is involved in the binding of certain non-peptide antagonists, but is not important for the action of the natural peptide agonist, substance P.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506676     DOI: 10.1016/0014-5793(93)80865-r

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.

Authors:  Zhan-Guo Gao; Aishe Chen; Dov Barak; Soo-Kyung Kim; Christa E Müller; Kenneth A Jacobson
Journal:  J Biol Chem       Date:  2002-03-12       Impact factor: 5.157

2.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

3.  Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering.

Authors:  C E Elling; T W Schwartz
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

4.  Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.

Authors:  P Picard; L Chrétien; R Couture
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors.

Authors:  H T Schambye; S A Hjorth; D J Bergsma; G Sathe; T W Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.